Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.64 |
| ▸ | LMNA | P02545 | 4/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | GAA | P10253 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | AKT1 | P31749 | 1/20 | 0.55 |
| ▸ | AKT2 | P31751 | 1/20 | 0.55 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.53 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.53 |
| ▸ | GCGR | P47871 | 1/20 | 0.53 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.53 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30476324 | 1.00 | L3MBTL1 (0.64) | L3MBTL1KDM4ELMNATDP1KMT2A | |
| SCHEMBL652142 | 0.96 | L3MBTL1 (0.57) | L3MBTL1KDM4ELMNATDP1KMT2A | |
| SCHEMBL31510226 | 0.96 | L3MBTL1 (0.57) | L3MBTL1KDM4ELMNATDP1KMT2A | |
| SCHEMBL23606773 | 0.92 | L3MBTL1 (0.56) | L3MBTL1KDM4ELMNATDP1KMT2A | |
| SCHEMBL24036921 | 0.89 | L3MBTL1 (0.57) | L3MBTL1KDM4ELMNATDP1KMT2A | |
| SCHEMBL5476339 | 0.89 | ALDH1A1 (0.67) | L3MBTL1KDM4ELMNATDP1KMT2A | |
| SCHEMBL5475289 | 0.89 | ALDH1A1 (0.67) | L3MBTL1KDM4ELMNATDP1KMT2A | |
| SCHEMBL13950894 | 0.89 | KDM4E (0.78) | L3MBTL1KDM4ELMNATDP1KMT2A | |
| SCHEMBL12317104 | 0.87 | ALDH1A1 (0.56) | L3MBTL1KDM4ELMNATDP1KMT2A | |
| SCHEMBL13726198 | 0.86 | KDM4E (0.75) | L3MBTL1KDM4ELMNATDP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116239576-A | Indole derivative and application thereof | 浙江八亿时空先进材料有限公司 | 2023-06-09 | — | — | CN | disclosed |
| WO-2021230651-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2021-11-18 | — | — | WO | disclosed |
| CN-112538061-A | Organic electroluminescent compound based on symmetric aromatic amine structure | 南京高光半导体材料有限公司 | 2021-03-23 | — | — | CN | disclosed |
| EP-2067778-B1 | Quinoxaline derivative, and light emitting element, light emitting device and electronic appliance using the same | SEMICONDUCTOR ENERGY LAB (JP) | 2016-08-17 | — | — | EP | disclosed |
| EP-2067778-B1 | Quinoxaline derivative, and light emitting element, light emitting device and electronic appliance using the same | SEMICONDUCTOR ENERGY LAB (JP) | 2016-08-17 | — | — | EP | disclosed |
| US-9056883-B2 | Organometallic complex, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-06-16 | — | — | US | disclosed |
| US-9056883-B2 | Organometallic complex, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-06-16 | — | — | US | disclosed |
| US-9056883-B2 | Organometallic complex, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-06-16 | — | — | US | disclosed |
| EP-2065378-B1 | Quinoxaline derivate, and light-emitting element, light-emitting device, and electronic device using quinoxaline derivative | SEMICONDUCTOR ENERGY LAB (JP) | 2015-01-28 | — | — | EP | disclosed |
| EP-2065378-B1 | Quinoxaline derivate, and light-emitting element, light-emitting device, and electronic device using quinoxaline derivative | SEMICONDUCTOR ENERGY LAB (JP) | 2015-01-28 | — | — | EP | disclosed |
| US-20080097094-A1 | DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS | ABBOTT LABORATORIES (US) | 2008-04-24 | — | — | US | disclosed |
| US-7319106-B2 | Diazabicyclic central nervous system active agents | ABBOTT LABORATORIES (US) | 2008-01-15 | — | — | US | disclosed |
| WO-2007108403-A1 | QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE USING THE QUINOXALINE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-09-27 | — | — | WO | disclosed |
| WO-2007108403-A1 | QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE USING THE QUINOXALINE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-09-27 | — | — | WO | disclosed |
| US-20070222374-A1 | Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070222374-A1 | Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070222374-A1 | Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
| US-6809105-B2 | (CIS)-6-(3-PYRIDINYL)-3,6-DIAZABICYCLO(3.2.0) HEPTANE FOR EXAMPLE; ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, ATTENTION DEFICIT HYPERACTIVITY DISORDER, DEPRESSION, NICOTINIC WITHDRAWAL SYNDROME, TOURETTE'S SYNDROME, AND SCHIZOPHRENIA | ABBOTT LABORATORIES | 2004-10-26 | — | — | US | disclosed |
| US-20040186107-A1 | Diazabicyclic central nervous system active agents | ABBVIE INC. | 2004-09-23 | — | — | US | disclosed |
| US-20020019388-A1 | Diazabicyclic central nervous system active agents | ABBVIE INC. | 2002-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080097094-A1 | DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS | GAP43, GABRE, CHRNA6 | L3MBTL1 4557/4885KDM4E 4017/4885LMNA 2377/4885 |
| US-20020019388-A1 | Diazabicyclic central nervous system active agents | GAP43, GABRE, CHRNA6 | L3MBTL1 4394/4885KDM4E 3864/4885LMNA 2415/4885 |
| US-20040186107-A1 | Diazabicyclic central nervous system active agents | GAP43, GABRE, CHRNA6 | L3MBTL1 4394/4885KDM4E 3864/4885LMNA 2415/4885 |
| US-20070222374-A1 | Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative | NDUFA9, MT-ND1, NQO2 | L3MBTL1 1414/4885KDM4E 2330/4885LMNA 2348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.